(CIDRAP News) – Reports of sporadic 2009 H1N1 infections and a few deaths in parts of India have sparked high-profile media coverage of the disease in the country, catching the attention of public health officials and vaccine makers, according to several media reports.
(CIDRAP News) – Lapses in health measures during the second season that the 2009 H1N1 flu virus circulated in England probably contributed to a heavier disease burden—marked by more deaths and hospitalizations—than during the 2009-10 pandemic, researchers reported today.
(CIDRAP News) – Armed with lessons learned during the 2009 H1N1 pandemic, government leaders in North America and Europe this week launched new guidance aimed at boosting preparedness for the next influenza pandemic.
(CIDRAP News) – A federal advisory board's reversal on publishing two controversial H5N1 studies is poised to shift discussions on the topic that continue in London this week, as more participants in the debate weigh in following the Mar 30 announcement.
(CIDRAP News) – In a set of articles published today in Nature, influenza experts say global flu surveillance—especially in poultry and swine—is sorely lacking and needs a major overhaul to make it more sustained, timely, and representative.
Mar 23, 2012
Editor's note: This story was revised on Mar 28, 2012, to correct the list of other cities that are working on medication-delivery programs similar to the one in the Twin Cities.
(CIDRAP News) – Infectious-disease specialty groups are teaming up to call for increased use of antimicrobial stewardship programs, saying such efforts can help preserve the effectiveness of anti-infective drugs while reducing medical costs.
(CIDRAP News) – Federal funding shortfalls have stalled the Center for Disease Control and Prevention's (CDC's) progress on establishing five centers of excellence that were included in the 2011 Food Safety Modernization Act (FSMA), according to sources involved in setting criteria for the new centers.
(CIDRAP News) – As part of its effort to shore up the waning supply of effective antimicrobials, the Infectious Diseases Society of America (IDSA) has proposed a streamlined approval pathway for antibiotics intended for special classes of patients who lack other treatment options.
